Confronting the complexity of EGFR/HER targeted therapies in breast, colorectal and lung cancers

A panel of European experts discusses current and emerging issues in breast, lung and colorectal cancers, highlighting possible shared approaches in a context of personalised cancer medicine.. They also critically discuss why we see success in one disease type but failures in others although they share the same underlying pathways.
From the first ESMO Signalling pathways symposium
http://www.esmo.org

Video produced by the European Society for Medical Oncology (ESMO)

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings